Cardiometry Versus Fluid and Catheter Treatment Trial (FACTT Lite) on Fluid Management in Acute Respiratory Distress Syndrome Patients

NACompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

January 10, 2020

Primary Completion Date

February 10, 2021

Study Completion Date

February 20, 2021

Conditions
ARDSFluid ManagementCardiometry
Interventions
DEVICE

Electrical cardiometry

Four sensors of EC will be applied : first approximately 5 cm above the base of the neck, second on the base of neck, third on the lower thorax at the level of the xiphoid and the fourth one on the lower thorax approximately 5 cm below the 3rd electrode at the level of anterior axillary line. The EC monitor (Electrical Cardiometry monitor, ICON Cardiotronics, Inc., La Jolla, CA 92307; Osyka Medical GmbH, Berlin, and Germany, model C3, serial number 1725303) will be connected to the sensor cable and the patient data will be fed. Corrected flow time (FTC) and stroke volume (SV) will be measured continuously in less than 30 seconds after placing the sensors and inputting the height and weight.

DRUG

"Fluid and Catheter Treatment Trial FACTT Lite"

The FACTT Lite provided three possible instructions determined by the CVP and urine output: furosemide administration, fluid bolus, or no intervention. FACTT Lite contained instructions to withhold furosemide until the patient achieved a mean arterial pressure greater than 60 mmHg off of vasopressors for at least 12 h.

Trial Locations (1)

31511

Tanta University Hospitals, Tanta

All Listed Sponsors
lead

Tanta University

OTHER

NCT04219150 - Cardiometry Versus Fluid and Catheter Treatment Trial (FACTT Lite) on Fluid Management in Acute Respiratory Distress Syndrome Patients | Biotech Hunter | Biotech Hunter